Back to top

This meeting is a combined vaccine and microbicide meeting...

The search for effective biomedical HIV prevention options has progressed further and changed faster in the last few years than at any time since the epidemic began. Recent breakthroughs in vaccines, ARV-based microbicides and PrEP, and other prevention technologies open new doors to reducing the scope of the global epidemic. This progress also poses new questions and brings new challenges as we continue to move HIV biomedical prevention research forward. Perhaps most importantly, these advances teach us that effective HIV prevention will likely require a combination of approaches.

To reflect this convergence, a new, broader prevention research conference, HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIV R4P) will be offered. This first HIV R4P biennial meeting will take place 28-31 October 2014 at the Cape Town International Conference Centre in Cape Town, South Africa.

HIV R4P will build on, link and merge the successes of the past biennial microbicide and annual vaccine conferences. This first international scientific meeting dedicated to biomedical HIV prevention research will bring together researchers, clinicians, private sector partners, advocates, policy makers and public health experts to share and discuss the latest research in ARV-based prevention, vaccines and related areas of HIV prevention. This meeting will help to cross-fertilize the various areas of research, develop a broader forum for common research themes and expand discussions around crosscutting issues as we develop, rollout and evaluate new prevention options.

For further information regarding this meeting, please see the HIV Research 4 Prevention website located at http://hivr4p.org.

DescriptionDateSize
Roadmap to Microbicide Trials Network Presentations (Download) 2014-10-21154.69 KB